Skip to main content
. 2017 Mar 27;7(3):e011482. doi: 10.1136/bmjopen-2016-011482

Table 1.

Biochemical parameters during the follow-up according to trajectory groups

‘Rapid PTH drop’ group
N=34 (12.7%)
“Gradual PTH decrease” group
N=98 (36.4%)
‘Slow PTH decrease with high phosphate’ group
N=105 (39.0%)
‘Uncontrolled SHPT’ group
N=32 (11.9%)
 
N Mean SD N Mean SD N Mean SD N Mean SD p Value*
Serum 25-OH vitamin D level (ng/mL)
 At baseline 31 17.2 11.8 67 18.7 12.2 68 20.1 16.2 22 22.5 13.2 0.53
 At 3 months 18 27.2 17.2 30 20.4 12.0 36 23.4 15.1 14 24.5 13.4 0.45
 At 6 months 15 31.3 21.0 37 21.9 11.4 38 22.1 15.0 9 27.6 15.5 0.15
 At 9 months 15 30.0 14.4 34 22.7 15.2 33 24.5 15.3 13 21.4 8.1 0.36
 At 12 months 15 30.5 14.4 37 26.8 14.5 37 27.7 34.6 15 23.9 13.8 0.89
 At 15 months 15 23.0 11.6 34 24.4 13.5 26 28.1 15.9 10 17.7 8.7 0.22
 At 18 months 15 30.5 16.7 26 27.0 18.2 36 28.3 14.2 11 26.3 16.0 0.90
 At 21 months 11 32.8 11.1 33 27.1 16.6 29 28.2 14.8 15 21.1 10.6 0.23
 At 24 months 10 36.9 17.1 31 26.5 18.0 24 25.8 13.9 13 24.1 12.0 0.22
Serum alkaline phosphatase level (UI/L)
 At baseline 34 94.5 36.1 96 102.0 46.1 104 98.3 44.5 31 162.1 199.2 <0.001
 At 3 months 31 101.1 48.6 85 98.0 41.7 96 101.3 48.0 28 176.8 185.4 <0.0001
 At 6 months 30 89.1 35.4 82 97.6 36.0 97 103.1 48.8 26 184.5 149.0 <0.0001
 At 9 months 29 79.4 32.0 76 97.9 41.0 94 100.4 40.3 25 200.2 169.1 <0.0001
 At 12 months 27 78.1 27.6 76 96.9 50.1 86 102.9 43.1 29 168.3   <0.0001
 At 15 months 25 85.2 39.9 65 101.7 74.0 79 107.7 58.6 29 165.7 134.3 0.0001
 At 18 months 24 93.3 44.3 67 96.2 38.9 69 103.5 53.9 25 158.3 117.7 <0.001
 At 21 months 21 82.0 33.8 62 94.9 36.4 68 103.3 48.2 25 151.1 81.3 <0.0001
 At 24 months 20 86.8 47.1 60 92.7 35.0 58 105.9 49.7 22 184.5 182.0 <0.0001
Serum albumin level (g/L)
 At baseline 33 35.4 5.6 92 36.4 4.3 102 35.8 4.5 31 37.4 4.4 0.28
 At 3 months 28 35.4 3.7 80 35.5 5.0 88 35.9 4.8 27 37.1 4.9 0.47
 At 6 months 31 35.8 5.0 74 35.6 5.3 88 36.9 4.8 25 37.2 5.4 0.28
 At 9 months 26 34.5 5.3 70 35.2 5.0 85 36.5 4.7 29 38.2 4.7 0.01
 At 12 months 26 33.8 5.5 68 34.9 5.4 77 35.4 5.0 25 37.4 5.4 0.10
 At 15 months 23 33.4 6.5 61 35.0 6.0 73 35.6 4.8 27 37.6 5.5 0.06
 At 18 months 24 32.9 6.9 61 35.4 5.7 70 35.8 5.7 25 36.5 5.5 0.14
 At 21 months 19 33.5 6.0 59 35.6 4.7 70 36.1 4.7 27 37.6 5.0 0.04
 At 24 months 17 35.1 3.6 54 35.6 5.1 65 36.2 5.4 21 38.1 3.3 0.18
Serum bicarbonate level (mmol/L)
 At baseline 34 22.4 3.3 98 22.2 3.6 103 22.1 3.3 32 22.1 4.3 0.97
 At 3 months 33 23.3 3.2 91 23.2 3.4 100 22.4 3.4 29 21.1 3.8 0.02
 At 6 months 32 23.1 2.6 87 23.4 3.7 97 22.6 3.9 30 22.1 2.7 0.26
 At 9 months 29 23.9 3.1 84 23.3 3.4 96 22.8 3.5 27 22.8 2.6 0.36
 At 12 months 27 23.7 3.1 80 22.8 3.1 88 23.1 4.0 25 22.0 3.2 0.31
 At 15 months 26 23.7 3.4 72 23.4 3.8 79 22.9 3.6 27 22.8 3.2 0.66
 At 18 months 26 24.2 3.1 72 23.3 3.7 80 23.1 4.0 27 22.0 3.1 0.16
 At 21 months 23 24.1 3.2 68 23.9 3.6 76 23.2 3.2 27 22.2 3.2 0.10
 At 24 months 21 24.1 2.6 63 24.3 3.8 73 23.5 3.5 26 22.6 3.0 0.15

Bold indicates statistical significance, p<0.05.

*Analysis of variance or Wilcoxon's test used to compare continuous variables.

PTH, parathyroid hormone; SHPT, secondary hyperparathyroidism.